Microneedle Drug Delivery CRO/CDMO
Hours: 8:30 AM–5:30 PMSales: +86 10 8928 7035Business: bd@casmn.com

MICRONEEDLE DEVELOPMENT INSIGHT

From Formulation to Scale-Up: Building a Manufacturable Microneedle Product

Laboratory prototypes must be translated into a repeatable process with defined material attributes, process parameters and analytical controls.
01

Direct Answer

Laboratory prototypes must be translated into a repeatable process with defined material attributes, process parameters and analytical controls.

02

Key Questions to Review

Use these questions to prepare a more productive initial discussion.

  • Critical formulation attributes
  • Drying and moisture control
  • Microneedle consistency
  • Scale-dependent risks
  • Analytical control and process transfer
03

Information Required

Start with non-confidential payload, dose, intended-use, development-stage and target-market information.

04

Technical Review

Reviewed by the CASMN Technical Team. Last reviewed: August 2026.

05

Related Capability

CASMN supports feasibility assessment, formulation and process development, analytical evaluation, pilot scale-up and project-specific manufacturing planning.

Request a Feasibility Assessment

Send your target product, payload, development stage and cooperation scope to our business development team.

Start a Project